The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
Open accessAbstract
Phaeochromocytomas (PHEO) and paragangliomas are rare catecholamine-producing tumours. Although 10-30% of these tumours metastasise, histopathological criteria to discriminate malignant from benign tumours have not been established; therefore, reliable histopathological markers predicting metastasis are urgently required. A total of 163 tumours, including 40 metastatic tumours, collected by the Phaeochromocytoma Study Group in Japan (PHEO-J) were analysed using a system called grading system for adrenal phaeochromocytoma and paraganglioma (GAPP). The tumours were scored based on GAPP criteria as follows: histological pattern, cellularity, comedo-type necrosis, capsular/vascular invasion, Ki67 labelling index and catecholamine type. All tumours were scored from 0 to 10 points and were graded as one of the three types: well-differentiated (WD, 0-2 points), moderately differentiated (MD, 3-6 points) and poorly differentiated (PD, 7-10 points). GAPP scores of the non-metastatic and metastatic groups were 2.08±0.17 and 5.33±0.43 (mean±s.e.m., P<0.001) respectively. There was a significant negative correlation between the GAPP score and the interval until metastasis (r=-0.438, P<0.01). The mean number of years until metastasis after the initial operation was 5.5±2.6 years. The study included 111 WD, 35 MD and 17 PD types. The five-year survival of these groups was 100, 66.8 and 22.4% respectively. In addition, negative immunoreactivity for succinate dehydrogenase gene subunit B (SDHB) was observed in 13 (8%) MD or PD tumours and ten of the 13 (77%) had metastases. Our data indicate that a combination of GAPP classification and SDHB immunohistochemistry might be useful for the prediction of metastasis in these tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A GAPP score of 0 to 2 is considered low risk, 3 to 6 intermediate risk, and 7 to 10 high risk.”
From Adrenal incidentaloma (2020) · cites this paper as [121]
In the citing paper
“Subsequently, Kimura et al. (121) developed a less involved scoring system for prediction of metastases, Grading of Adrenal Pheochromocytoma and Paraganglioma (GAPP) consisting of a smaller number of pathological parameters with weighted scoring (1 or 2 points) including histological pattern; cellularity; comedo necrosis; capsular/vascular invasion; Ki67 proliferative index; and catecholamine phe”
From Adrenal incidentaloma (2020) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Thompson, L. D. R. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200205000-00002 · Cited by 715
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 554
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 542
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Castro‐Vega, L. J., Buffet, A., de Cubas, A. A., Cascón, A., Menara, M., Khalifa, E., Amar, L., Azriel, S., Bourdeau, I., Chabre, O., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt639 · Cited by 412
Eisenhofer, G., Lenders, J. W. M., Siegert, G., Bornstein, S. R., Friberg, P., Milosevic, D., Mannelli, M., Linehan, W. M., Adams, K. T., Timmers, H. J. L. M., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.016 · Cited by 375
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D. A., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 374
Linnoila, R. I., Keiser, H. R., Steinberg, S. M., & Lack, E. E. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90155-x · Cited by 373
The diagnosis and management of malignant phaeochromocytoma and paraganglioma
Chrisoulidou, A., Kaltsas, G., Ilias, Ι., & Grossman, A. B. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0074 · Cited by 310
Start, R. D. (2000) · Histopathology · doi:10.1046/j.1365-2559.2000.01097.x · Cited by 304
Flagged first, then by citations
Research works printed but not linked: 5
- Gimenez-Roqueplo, 2003, Cancer Research, 63, 5615
- 2013, Molecular and cellular endocrinology, 386, 92
- Nagura, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 12, 1107
- 2011, Endocrine Reviews, 32
- 1991, ARCHIVES OF PATHOLOGY LABORATORY MEDICINE, 115, 484
Cited by
Sorted by citations
Items 301–391 of 391
Autopsy of malignant paraganglioma causing compressive myelopathy due to vertebral metastases
Sakuma, M., Hiroi, A., Yamamoto, T., Sawada, T., Ichihara, A., Sakai, S., Amano, T., Kobayashi, D., Shibata, N., & Nagashima, Y. (2020) · Neuropathology · doi:10.1111/neup.12690
Okamoto, T., & Yoshida, Y. (2021) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.82.14
Retroperitoneal paraganglioma with hypertensive crisis during laparoscopic surgery
Fukuzawa, T., Yamaki, S., Irie, M., Sasaki, H., Kudo, H., Nakamura, M., Ando, R., Okubo, R., Endo, Y., Hashimoto, M., et al. (2021) · Journal of Pediatric Surgery Case Reports · doi:10.1016/j.epsc.2021.102029
Paraganglioma Presenting Atypical Initial Symptoms: a Case ReportPreprint
Eguchi, S., Ono, R., SATO, T. A., Yada, K., Umehara, N., Narumi, S., Ichihashi, Y., Nozaki, T., Kanomata, N., Hasegawa, T., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-801163/v1
Farolfi, A., Maietti, E., Piperno, F., Coppolino, P., Dalmazi, G. D., Zavatta, G., Leo, A. D., Cintio, I. D., Fanti, S., Golfieri, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-927691/v1
Selección de poemas inéditos conservados en el Archivo Juan Gil-Albert de la Biblioteca Valenciana
Cubells, P. E., & Ferrer, J. F. M. (2004) · Laberintos: revista de estudios sobre los exilios culturales españoles
Así se escribe la Historia: la Movida de Madrid, de súbditos a ciudadanos
Iturralde, J. I. S. (2005) · La Aventura de la historia
Rosa, S. L. (2021) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5560-1
Genetics of Phaeochromocytomas, Paragangliomas, and Neuroblastoma
Maher, E. R., & Casey, R. T. (2022) · doi:10.1093/med/9780198870197.003.0097
Familial Syndromes and Genetic Causes of Paraganglioma and Phaeochromocytoma
Maher, E. R., & Casey, R. T. (2022) · doi:10.1093/med/9780198870197.003.0119
Hereditäres Phäochromozytom und Paragangliom
Alesina, P. F., & Walz, M. K. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-61724-3_35-1
Zhang, C., Kang, Y., Jiao, H., Hu, Y., Chang, D., & Yang, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1601822/v1
Uccella, S., & Pettenon, F. (2021) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5311-1
Clinical Diagnosis and Treatment of Malignant (Metastatic) Carotid Body Tumor
张, 正. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126797
Paraganglioma of the urinary bladder mimicking a urothelial carcinoma: a case report
Öztürk, Ç. P., Güçer, H., Altuntaş, S. Ç., & Okçu, O. (2022) · The European Research Journal · doi:10.18621/eurj.1032176
A Rare Case of a Right Atrial Paraganglioma in an Individual with the SHDB Mutation
Lancaster, I., Núñez, C., Willinger, A., Caldeira, C., & Aufman, J. J. (2022) · Case Reports in Cardiology · doi:10.1155/2022/1140976
Burciulescu, S. M. L., & Gheorghiu, M. L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108298
Hereditäres Phäochromozytom und Paragangliom
Alesina, P. F., & Walz, M. K. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-63317-5_35
Tang, S. S. L., Lee, J. W. K., Wijerethne, S., Iyer, S. G., Hue, S. S., En, N. M., & Parameswaran, R. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02817-6
Uccella, S., & Pettenon, F. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5311
Rosa, S. L. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62345-6_5560
Case report: Bilateral carotid body tumors with a concomitant skull-base paraganglioma
Liu, Z., Yue, R., Sun, C., & Wang, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1120152
Qin, S., Xu, Y., Yu, S., Han, W., Fan, S., Ai, W., Zhang, K., Wang, Y., Zhou, X., Shen, Q., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.26.534245
Comprehensive Genetic Study of Malignant Cervical Paraganglioma
Snezhkina, A. V., Pavlov, V., Fedorova, M., Kalinin, D. V., Pudova, E. A., Kobelyatskaya, A. A., Bakhtogarimov, I. R., Krasnov, G. S., & Kudryavtseva, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098220
Vietor, N. O. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0605
Expression of EMP 1, 2, and 3 in Adrenal Cortical Neoplasm and Pheochromocytoma
Cha, Y. J., & Koo, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241613016
A Case of Neurofibromatosis Type 1 Diagnosed with Pheochromocytoma after Breast Cancer Surgery
TANIGUCHI, E., & Inaishi, T. (2023) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.84.340
Хусейн, С. Х., Пархоменко, Л. Б., & Ruksha, K. (2023) · Евразийский онкологический журнал · doi:10.34883/pi.2023.11.2.014
Qin, S., Xu, Y., Yu, S., Han, W., Fan, S., Ai, W., Zhang, K., Wang, Y., Zhou, X., Shen, Q., et al. (2023) · eLife · doi:10.7554/elife.87586.1
Gaillard, F., Ashraf, A., & Campos, A. (2010) · Radiopaedia.org · doi:10.53347/rid-8642
Lloyd, R. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-39554-3_13
Secondary Hypertension: Pheochromocytoma and Paraganglioma
Cohen, D. L., & Fishbein, L. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00015-3
Evaluation of adrenal masses using 18F-FDOPA PET/CT in patients suspected with pheochromocytoma
Kim, S. J., Park, C., Kwon, H., & Kim, Y. H. (2023) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001781
Yanagida, J., Yoshida, Y., NAKAI, T., Onizuka, H., Omi, Y., Horiuchi, K., Nagashima, Y., & Okamoto, T. (2023) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.84.941
Utalieva, D. T., Наймушина, П. А., Ахаладзе, Д. Г., Kournikova, M. A., Kletskaya, I. S., Андреева, Н. А., Римович, Т. С., Ускова, Н. Г., Вадимович, Т. И., Кривоносов, А. А., et al. (2023) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2023-22-4-63-72
Qin, S., Xu, Y., Yu, S., Han, W., Fan, S., Ai, W., Zhang, K., Wang, Y., Zhou, X., Shen, Q., et al. (2024) · eLife · doi:10.7554/elife.87586.2
Adrenal Multidisipliner Güncel Yaklaşım
Özen, F. Z., Özer, M., Özsoy, Ç., Binnetoğlu, E., Alparslan, A. Ş., Budak, E. S., Kök, E. V., Çetinkaya, G. S., Durmuş, M. E., Köker, G., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2992
Kojima, F., Ohno, K., Fushimi, N., Takahashi, R., Tasaki, A., & Asakage, T. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2023.12.002
Diagnostic and prognostic utility of INSM1, ISL1 and secretagogin in pheochromocytomaPreprint
Sözen, M., Turan, G., Cantürk, Z., Çetinarslan, B., Selek, A., Tosun, M., Civriz, A. H., Sevinç, B., Gezer, E., & Köksalan, D. (2024) · Research Square · doi:10.21203/rs.3.rs-4322745/v1
Current peri-operative and surgical management of bladder paraganglioma
Gharbieh, S., Lobo, N., Velusamy, A., McCanny, J., Thurairaja, R., Khan, M. S., & Nair, R. (2024) · Journal of Clinical Urology · doi:10.1177/20514158241262086
Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma
Trucco, G. V., & Volante, M. (2024) · Updates in surgery/Updates in surgery series · doi:10.1007/978-3-031-62301-1_14
Niaz, Z., Ismail, B., Faraï, A. A., Telugu, R. B., Usmani, S., & Haddabi, I. H. A. (2024) · Journal of the Oman Medical Association · doi:10.3390/joma1010010
Pheochromocytoma and Adrenal Medullary Hyperplasia
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-08
Paraganglia and Paragangliomas
(2024) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477473-09
Nockel, P. J., Lakis, M. E., & Kebebew, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00230-2
Naoki, Y., Kaneko, T., Numakura, S., Yamamoto, A., Noda, M., Tokura, Y., Yoshimura, I., Kawai, T., Sasajima, Y., & Nakagawa, T. (2025) · GHM Open · doi:10.35772/ghmo.2024.01010
An overview of pertinent immunohistochemistry and molecular pathology of phaeochromocytoma
Chetty, R. (2025) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2025.06.005
Metastatic Malignant Phaeochromocytoma in Ascitic Fluid: Cytological Diagnosis of a Rare Entity
Brockmoeller, S. F., Lajara, S. B., & Khader, S. N. (2025) · Cytopathology · doi:10.1111/cyt.70003
An Unusual Presentation of Pheochromocytoma Accompanied by Catecholamine-Induced Cardiomyopathy
Roberts, H. O. J., Munteanu, A. C., & Mertens, J. E. (2025) · ESC Heart Failure · doi:10.1002/ehf2.15328
(2025) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477619-8
Predictive Factors of Malignancy in Cervical Paragangliomas: A Retrospective Study
Haw, G., Fieux, M., Flaus, A., Lasolle, H., Abeillon, J., Decaussin‐Petrucci, M., Pavie, D., Vérillaud, B., Herman, P., Feugier, P., et al. (2025) · Head & Neck · doi:10.1002/hed.28250
Wang, Y., Zhu, J., Ma, W., Yang, J. L., Zhong, H., Wu, J.-J., Wu, K., Hu, A., & Wu, J. (2025) · Vascular · doi:10.1177/17085381251360125
Late‐Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report
Ishizaki, F., Hiruma, K., Tani, Y., Sugino, H., Sanami, T., Anraku, T., Ikeda, M., Tasaki, M., Saito, K., & Tomita, Y. (2025) · IJU Case Reports · doi:10.1002/iju5.70086
Babayeva, M., Çakır, O. K., Huseynova, G., & Süleyman, H. (2025) · Archives of Basic and Clinical Research · doi:10.4274/abcr.2025.24317
van den Berg, M. F., Ruiz, A. M., Zandvliet, M. M. J. M., van Nimwegen, S. A., Kooistra, H. S., Galac, S., & Grinwis, G. C. M. (2025) · Veterinary and Comparative Oncology · doi:10.1111/vco.70021
Case Report: A rare case of primary hepatic paraganglioma: a mimicker of hepatocellular carcinoma
Li, A., Ren, S., Yang, X., Yang, C. M., & Lu, T. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1570896
Alrayes, B. M. H., Al-Shami, N. A., Hamedat, A. W., Khalil, A., Hijazi, E., & Shibani, B. (2025) · Cureus · doi:10.7759/cureus.92737
Литвяков, М. А., O'Neill, D. G., Brodbelt, D. C., Galac, S., & Buishand, F. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332811
Gallbladder and cystic duct paraganglioma requiring cystic duct re-excision
Abdelaziz, R., Ayoub, G., Elberm, H., Tarek, R., & Hazeem, J. A. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-268038
Sözen, M., Turan, G., Cantürk, Z., Çetinarslan, B., Selek, A., Tosun, M., Civriz, A. H., Sevinç, B., Gezer, E., & Köksalan, D. (2025) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20250504
Succinate dehydrogenase deficiency
Ordidge, K., Pappachan, J. M., Fernandez, C. J., & Sahdev, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27354-4.00011-9
Kaede, B. A. B. A., Hiraki, M., Okuyama, K., Takesue, S., Manabe, T., & Noshirο, H. (2025) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.86.545
Faraman, M. A., Albostani, A., Faraman, R. A., & Al‐Saleh, W. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.101031
Tarbaeva, N. V., Manaev, A. V., Chevais, A., Beltsevich, D. G., Urusova, L. S., Канаматовна, Э. А., Александровна, Р. А., Mel'nichenko, G. A., & Mokrysheva, N. G. (2025) · Terapevticheskii arkhiv · doi:10.26442/00403660.2025.10.203371
Sclerotic Head and Neck Paragangliomas: An Unfavorable Indicator Associated With Surgical Outcomes
Yao, C., Cao, D., Feng, Y., Ding, Y., Zhou, J., Huang, Z., Piao, Y., Yu, Z., & Chen, X. (2025) · Head & Neck · doi:10.1002/hed.70049
Current Understanding of Carotid Body Paraganglioma Management
Kim, Y.-W. (2025) · Vascular Specialist International · doi:10.5758/vsi.250063
Jones, A. S., Jacob, P. M., Philip, R. C., & Muralidharan, K. (2025) · Indian Journal of Endocrine Surgery and Research · doi:10.5005/jp-journals-10088-11266
Paragangliomi: pro e contro degli score di rischio
Canu, L., & Zanatta, L. (2026) · L Endocrinologo · doi:10.1007/s40619-026-01744-y
Interpretable Machine Learning for Metastasis Prediction in Paragangliomas and Pheochromocytomas
García-Barceló, C., Bernabeu, D., Gil, D., Mora, H., Ortuño‐Miquel, S., & Gómez, P. H. (2026) · Springer proceedings in complexity · doi:10.1007/978-3-032-09066-9_26
Goncalves, P. D., & Sadow, P. M. (2026) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000528 · Cited by 1
Hayase, T., Takashima, H., Sawada, Y., Mitsui, R., Tsuboi, T., Morimoto, H., Fukushima, J., & Hayashi, S. (2026) · Urology Case Reports · doi:10.1016/j.eucr.2026.103363
Sedogo, R. B. H., Ido, F. A. H. A., Ouédraogo, A. S., Sidibé, A., Bocovo, E. J., Yoni, S.-B. H., Somé, D. R. N., Ouedraogo, A. S., & Mokni, M. (2026) · Open Journal of Pathology · doi:10.4236/ojpathology.2026.162011
Malignant Potential of Temporal Bone Paragangliomas With Reference to GAPP System
Komune, N., Taniguchi, M., Kida, Y., Kuga, R., Kuga, D., Arimura, K., Fujiwara, Y., Yamamoto, H., Oda, Y., Yoshimoto, K., et al. (2026) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.70370
Yanagida, J., Horiuchi, K., Yoshida, Y., & Yamamoto, T. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag038
Zhou, Y., Zhang, Z., Zhou, K., Tan, Y., Zhao, J., Zhong, L., Wei, X., Zhu, J., Li, Z., Du, J., et al. (2026) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2026.111851
Halperin, R., Goldinger, G., Fridman, E., Peshes‐Yaloz, N., Tirosh, A., & Shlomai, G. (2026) · Cancers · doi:10.3390/cancers18121983
Paraganglioma of the Urinary Bladder: Clinicopathological Features of 7 Cases
Zhang, Y., & Cui, D. (2026) · Galician Medical Journal · doi:10.21802/e-gmj2026-a16
SDHB and CDK1 protein expression in metastatic pheochromocytoma and paraganglioma
Gunnesson, L., Karakaya, S., Mohlin, S., Muth, A., & Elias, E. (2026) · Endocrine Oncology · doi:10.1530/eo-26-0035
Biomarkers of metastatic disease in pheochromocytoma and paraganglioma
Donato, S., Herrera-Martínez, A. D., Jacome-Gaibor, V. A., Ruz‐Caracuel, I., Toledo, R., & Castro, M. A. (2026) · Endocrine Connections · doi:10.1530/ec-26-0501
Asoglu, H., Asarkaya, E., Aykut, A., Dorukhan, C. G., Camadan, Y. A., Kolsuz, İ., Demirköse, H., Köşeci, T., Bayram, E., Akkuş, G., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16162516
Wiejak, A.-M., Constantinescu, G., Žygienė, G., Robledo, M., Ziegler, C. G., Kühn, J., de Krijger, R. R., Pamporaki, C., Meinhardt, M., & Bechmann, N. (2026) · Endocrine Pathology · doi:10.1007/s12022-026-09931-1
de Bresser, C. J. M., & de Krijger, R. R. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.101051
Ünsal, İ. Ö., Üçgül, E., Unver, C. K., Dizdar, N., Hepşen, S., Çalapkulu, M., Karaoglu, A. E., Çayır, D., & Çakal, E. (2026) · Diagnostics · doi:10.3390/diagnostics16172858
ISHIZONE, A., Yuiru, O. G. A., KAWAGUCHI, E., IWATA, T., MOTOKI, Y., KASHIMA, T., & Fuyuko, T. O. I. (2026) · Journal of the Japan Veterinary Medical Association · doi:10.12935/jvma.79.e231
BURGUCU, H. Ç., Günler, T., Ömeroğlu, E., Ünlü, Y., & Aksu, O. (2026) · Pathophysiology · doi:10.3390/pathophysiology33040072
Casey, R. T., & Lussey‐Lepoutre, C. (2026) · Endocrine Related Cancer · doi:10.1530/erc-26-0310
Zhang, W., Zhou, Y., Cui, Y., Li, T., Li, Z., Ren, W., & Tong, A. (2026) · Endocrine · doi:10.1007/s12020-026-04811-4
Icin, B. B., Uzun, Ö., ÇAKIR, B., Balsak, B. Ö. T., İmga, N. N., Soltanova, L., Kadıoğlu, P., Kimyon, Ö. Ş., Çiftçi, S., Alibakan, Ö. K., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.10.005
Chen, H. G., Li, H., Zhang, D., & Zhou, F. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.08.238
Metadata
- Authors
- Kimura, N., Takayanagi, R., Takizawa, N., Itagaki, E., Katabami, T., Kakoi, N., Rakugi, H., Ikeda, Y., Tanabe, A., Nigawara, T., Ito, S., Kimura, I., Naruse, M., & _, _.
- Affiliations
- National Hospital Organization (JP)
- Kyushu University (JP)
- Kansai Medical University (JP)
- Kyorin University (JP)
- St. Marianna University School of Medicine (JP)
- Miyagi Prefectural Hospital Organization (JP)
- The University of Osaka (JP)
- Nihon University Itabashi Hospital (JP)
- Tokyo Women's Medical University (JP)
- Hirosaki University (JP)
- Tohoku University (JP)
- Ministry of Health Labour and Welfare (JP)
- Kyoto Medical Center (JP)
- ORCID
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2014-02-12
- Volume
- 21
- Issue
- 3
- Pages
- 405-414
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2153367841
- Cited by
- 393
- References
- 25
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 42 · 2023: 41 · 2022: 51 · 2021: 39 · 2020: 24 · 2019: 27 · 2018: 27 · 2017: 27 · 2016: 21 · 2015: 10 · 2014: 6
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shimane University
- Tokyo Medical and Dental University
- Jikei University School of Medicine
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- pheochromocytoma, paraganglioma, metastasis prediction, tumor grade, SDHB immunohistochemistry, Ki-67 labelling index, comedo necrosis, capsular invasion, survival
- MeSH terms
- Adrenal Gland Neoplasms, Adult, Aged, Aged, 80 and over, Catecholamines, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Male, Middle Aged, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Prognosis, Succinate Dehydrogenase, Biomarkers, Tumor, Survival Rate, Case-Control Studies, Young Adult, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review